News & Views
Telix Pharmaceuticals is pleased to provide its Quarterly Shareholder Update presentation and the transcript of CEO Dr Chris Behrenbruch’s conference call with…
Read more
Telix provides its Appendix 4C for the quarter ending 31st March 2020 and a Q1 2020 sales update for its prostate cancer imaging…
Read more
Telix Pharmaceuticals provides notice of The Annual General Meeting of the Shareholders on Tuesday 12 May…
Read more
Telix Pharmaceuticals (U.S.) Inc. is pleased to announce it has entered into a commercial agreement with Cardinal…
Read more
Telix is pleased to announce it has now completed the acquisition of a licensed radiopharmaceutical production facility in Seneffe,…
Read more
Telix and partners receive $500K research grant from Government-funded Innovative Manufacturing CRC to advance manufacturing of novel cancer…
Read more
News,
Telix provides an update on the Company’s risk management assessment of the novel coronavirus (COVID-19)…
Read more
News,
Telix Pharmaceuticals Limited is pleased to announce that Professor Dr. Frederik L. Giesel, MD, MBA has joined Telix’s Scientific Advisory Board…
Read more
Telix Pharmaceuticals announces that it has received positive feedback from the FDA regarding its submission of an NDA for…
Read more
Telix Pharmaceuticals Limited Releases Annual Report Year Ending…
Read more